|
1 |
LYN fördert die Leukämie-Unterstützung durch Fibroblasten im CLL-Mikromilieu via Regulierung von c-JUN und Thrombospondin-1
vom Stein, Alexander F.. - Köln : Universitäts- und Stadtbibliothek Köln, 2025
|
|
|
|
2 |
Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21): a randomised, multicentre, parallel, open-label, phase 3 trial
Borchmann, Peter. - Augsburg : Universität Augsburg, 2024
|
|
|
|
3 |
Bendamustine followed by ofatumumab and ibrutinib in chronic lymphocytic leukemia: primary endpoint analysis of a multicenter, open-label, phase II trial (CLL2-BIO)
Cramer, Paula. - Würzburg : Universität Würzburg, 2024
|
|
|
|
4 |
Chronische lymphatische Leukämie
Eichhorst, Barbara. - Bremen : UNI-MED Verlag AG, 2024, 6., neubearb. Auflage
|
|
|
5 |
Chronische lymphatische Leukämie
Eichhorst, Barbara. - Bremen : UNI-MED, 2024, 6. Auflage
|
|
|
|
6 |
Neuregelung des assistierten Suizids
Domschke, Katharina. - Mannheim : Universitätsbibliothek Mannheim, 2024
|
|
|
7 |
Post-transplant-cyclophosphamide plus everolimus as GvHD prophylaxis in refractory T- and B-cell lymphoma
Enthalten in Bone marrow transplantation 15.11.2024: 1-3
|
|
|
|
8 |
Treatment with idelalisib in patients with chronic lymphocytic leukemia – real world data from the registry of the German CLL Study Group
Enthalten in Annals of hematology 26.6.2023: 1-8
|
|
|
|
9 |
Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic
Arndt, Volker. - Aachen : Universitätsbibliothek der RWTH Aachen, 2022
|
|
|
|
10 |
CD20 expression as a possible novel prognostic marker in CLL: application of euroflow standardization technique and normalization procedures in flow cytometric expression Analysis
Schilhabel, Anke. - Ulm : Universität Ulm, 2022
|
|
Administration
